Literature DB >> 25676515

Pathogenesis and risk factors for nontuberculous mycobacterial lung disease.

Jennifer R Honda1, Vijaya Knight2, Edward D Chan3.   

Abstract

Nontuberculous mycobacteria (NTM) infections are broadly classified as skin and soft tissue infections, isolated lung disease, and visceral or disseminated disease. The degree of underlying immune abnormalities varies between each classification. Skin and soft tissue infections are usually the result of iatrogenic or accidental inoculation of NTM in otherwise normal hosts. Visceral and disseminated NTM disease invariably occurs in individuals with more severe immunosuppression. Although the focus of this article is to discuss the pathogenesis of NTM lung disease, the risk factors of visceral/disseminated NTM disease are also summarized, as they provide insights into host-defense mechanisms against these organisms. Published by Elsevier Inc.

Entities:  

Keywords:  Lung disease; Nontuberculous mycobacteria; Pathogenesis; Risk factors

Mesh:

Year:  2014        PMID: 25676515     DOI: 10.1016/j.ccm.2014.10.001

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  37 in total

Review 1.  Exploring immunomodulation by endocrine changes in Lady Windermere syndrome.

Authors:  M R Holt; J J Miles; W J Inder; R M Thomson
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

2.  Changes in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Go Eun Yang; Yousang Ko; Yong Bum Park; Yun Su Sim; Sung Hoon Park; Chang Youl Lee; Ki-Suck Jung; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis.

Authors:  Mehdi Mirsaeidi; Ruxana T Sadikot
Journal:  Int J Mycobacteriol       Date:  2015-06

4.  Performance of a Highly Sensitive Mycobacterium tuberculosis Complex Real-Time PCR Assay for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting: a Prospective Intervention Study.

Authors:  Víctor Vinuesa; Rafael Borrás; María Luisa Briones; María Ángeles Clari; Vicenta Cresencio; Estela Giménez; Carmen Muñoz; Rosa Oltra; Emilio Servera; Talia Scheelje; Carlos Tornero; David Navarro
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

5.  A Rhesus Macaque Model of Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Kevin Winthrop; Andrea Rivera; Flora Engelmann; Sasha Rose; Anne Lewis; Jennifer Ku; Luiz Bermudez; Ilhem Messaoudi
Journal:  Am J Respir Cell Mol Biol       Date:  2016-02       Impact factor: 6.914

6.  Clinical features of infection caused by non-tuberculous mycobacteria: 7 years' experience.

Authors:  Tatjana Adzic-Vukicevic; Aleksandra Barac; Ana Blanka-Protic; Marija Laban-Lazovic; Bojana Lukovic; Vesna Skodric-Trifunovic; Salvatore Rubino
Journal:  Infection       Date:  2018-02-23       Impact factor: 3.553

7.  Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Authors:  Sun Hye Shin; Byung Woo Jhun; Su-Young Kim; Junsu Choe; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 8.  Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections.

Authors:  Jan-Willem Alffenaar; Anne-Grete Märtson; Scott K Heysell; Jin-Gun Cho; Asad Patanwala; Gina Burch; Hannah Y Kim; Marieke G G Sturkenboom; Anthony Byrne; Debbie Marriott; Indy Sandaradura; Simon Tiberi; Vitali Sintchencko; Shashikant Srivastava; Charles A Peloquin
Journal:  Clin Pharmacokinet       Date:  2021-03-10       Impact factor: 6.447

Review 9.  Non-tuberculous mycobacteria immunopathogenesis: Closer than they appear. a prime of innate immunity trade-off and NTM ways into virulence.

Authors:  Marisa Cruz-Aguilar; Antonia I Castillo-Rodal; René Arredondo-Hernández; Yolanda López-Vidal
Journal:  Scand J Immunol       Date:  2021-06-22       Impact factor: 3.889

10.  Risk for cardiovascular disease in patients with nontuberculous mycobacteria treated with macrolide.

Authors:  Jieun Kang; Ye-Jee Kim; Tae Sun Shim; Kyung-Wook Jo
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.